![Alexander Cumbo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Cumbo
Directeur Général chez
SOLID BIOSCIENCES INC.
Fortune : 2 M $ au 31/07/2026
Profil
Mr. Alexander G.
Cumbo is an Independent Director at Vor Biopharma, Inc., an Independent Director at Climb Bio, Inc. and a President, Chief Executive Officer & Director at Solid Biosciences, Inc. He is on the Board of Directors at Vor Biopharma, Inc., Climb Bio, Inc. and Solid Biosciences, Inc. Mr. Cumbo was previously employed as an Independent Director by Verve Therapeutics, Inc., a President, Chief Executive Officer & Director by AavantiBio, Inc., an Independent Director by RA Pharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Sarepta Therapeutics, Inc., and a Vice President-Sales & Treatment Education by Vertex Pharmaceuticals, Inc. He also served on the board at Clinical Supplies Management, Inc. He received his undergraduate degree from Auburn University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOLID BIOSCIENCES INC. 0,24 % | 31/03/2026 | 235 405 ( 0,24 % ) | 2 M $ | 31/07/2026 |
CLIMB BIO, INC. -.--% | 05/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
VOR BIOPHARMA, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Alexander Cumbo
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur Général | 02/12/2022 |
| CLIMB BIO, INC. | Directeur/Membre du Conseil | 28/03/2025 |
| VOR BIOPHARMA INC. | Directeur/Membre du Conseil | 16/07/2025 |
Anciens postes connus de Alexander Cumbo
| Sociétés | Poste | Fin |
|---|---|---|
| VERE THER | Directeur/Membre du Conseil | 25/07/2025 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Directeur Général | 01/12/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2020 |
| RA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/04/2020 |
Clinical Supplies Management, Inc.
 Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Offers clinical trial services to biotechnology and pharmaceutical companies | Directeur/Membre du Conseil | 01/01/2017 |
Formation de Alexander Cumbo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Auburn University
 Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Offers clinical trial services to biotechnology and pharmaceutical companies | Health Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
